Notice of Proposed Sale · 144
Belite Bio, Inc.
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- Belite Bio, Inc.
- Issuer CIK
- 0001889109
- SEC file number
- 001-41359
- Phone
- 858-246-6240
- Person for whose account securities are to be sold
- Hendrik Peter Scholl
- Relationships to issuer
- Officer
- Street
- 12750 High Bluff Drive
- Street (continued)
- Suite 475
- City
- San Diego
- State / country code
- CA
- Postal code
- 92130
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| American Depositary Shares, each representing one ordinary share | 4,000 | 679,280 | 39,339,960 | 10/01/2026 | NASDAQ | J.P. Morgan Securities LLC |
Broker / market maker — proposed row 1, entry 1
- Name
- J.P. Morgan Securities LLC
- Street
- 270 Park Avenue, 10th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10017
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| American Depositary Shares, each representing one ordinary share | 10/08/2025 | RSU Vesting | Issuer | 4,000 | N | 10/08/2025 | Compensation |
Prior-sale reporting
- Nothing to report for the preceding three months
- Y
Remarks
The shares covered by this filing will be sold by Bioptima AG, Hendrik Peter Scholl as Director. The shares will be sold today or within three months from the date of this filing.
Notice signature
- Notice date
- 10/01/2026
- Signed
- /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Hendrik Peter Scholl
- Plan adoption dates
- 06/25/2026